Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Sorrento Therapeutics Inc (SRNE)

OTC Markets
Currency in USD
Disclaimer
0.0275
0.0000(0.00%)
Closed

SRNE Comments

seriously what's the deal with this company every week a good news come to play and nothing happens come on already show some appreciation we should be at 10 plus this level is for loosers
Because I think this only sells good news. Dive deeper into their thrustwothiness. There are 400 tests approved in US. Covistix not among them. Every good news comes from Brazil, Mexico, China. Look at Mr. Ji other companies...SRNE is sued by investors...etc. Mr. Ji, inventor, - actually has PhD in animal physiology...might all be ok..but..might also be diluted soon ..back at 2,50..Also Mr. Ji s emphasis on being PhD...I guess they all are...but MRNA s CEO does not call himself Dr.
come on, it's good news so start moving up... go go go
Sorrento’s license partner submits socazolimab NDA in China for cervical cancer https://seekingalpha.com/news/3761389-sorrentos-license-partner-submits-socazolimab-nda-in-china-for-cervical-cancer?source=Drive
guys be ready today was a test I really believe tomorrow will be a good entry if not then Friday but next week this will be in the 9s for sure so good luck
Lets hope so 🤞🤞
we will prevail they saving us a 40% jump on a day and after that 12 range
will go back up to 13 till the end of the year....
wich year?
wow, what a rally, almost 2%
LoL 😂
go go
Sorrento Therapeutics rapid COVID test receives CE mark https://seekingalpha.com/news/3755685-sorrento-therapeutics-rapid-covid-test-receives-ce-mark?source=Drive
Patience people.. patience… 16-24 months… been here 12 months already
I see you're still hanging in there. Me too! Hopefully we'll see some good news soon !
bro nothing can make this stock to go to where it supposed to be which is 9s this is a dead cat
Sorrento gets FDA OK to start mid-stage pain study https://seekingalpha.com/news/3752388-sorrento-gets-fda-ok-to-start-mid-stage-pain-study?source=Drive
Sorrento Therapeutics: Wide Oncology Pipeline, And Watch Out For COVID Updates https://seekingalpha.com/article/4459163-sorrento-therapeutics-wide-oncology-pipeline-and-watch-out-for-covid-updates?source=Drive
SRNE is about way more than covid, non opioid pain medication can soar this stock, or create a merger
worst stock ever
-40% in 3 Months
Tell me bout it 😫
maybe now -50% ?
whats going on??
buuuuuuuuuu
Sorrento reports results of Covistix and Panbio antigen rapid tests for COVID-19 detection https://seekingalpha.com/news/3741031-sorrento-reports-results-of-covistix-and-panbio-antigen-rapid-tests-for-covid-19-detection?source=Drive
Good news, i hope we get away with only 2-3% down today
maybe we need some bad news to go up, if we go down more than 4% for good news
Sorrento reports results of Covistix and Panbio antigen rapid tests for COVID-19 detection https://seekingalpha.com/news/3741031-sorrento-reports-results-of-covistix-and-panbio-antigen-rapid-tests-for-covid-19-detection?source=Drive
the usual ****
I am a bit nervous about earnings. Is anyone else?
don't worry. it is not critical things for us now
calm down, Sorrento will ruin, as usual
this stock has a great future behind its shoulders
manipulation all the way watch after hours this will fly to 10s and Monday back to 9s or even 8s who knows worst of the worst seriously
Great news!
https://finance.yahoo.com/news/sorrento-announces-lead-protein-based-202100946.html
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.